Understand · Treat · Recover

Staging and Imaging

Staging maps the extent of cancer so the team can choose a realistic treatment goal and avoid unnecessary procedures.

For patients, families and caregivers worldwide. Approvals, access and care pathways vary by country. Evidence checked 21 October 2026.

This information is provided for general educational purposes and does not replace individualized medical advice. Diagnosis and treatment decisions should be made with a qualified healthcare team.

Chapter 6 of 20

TNM and stage groups

T describes how deeply the tumour invades and which nearby structures are involved. N describes regional lymph-node involvement. M describes distant spread. Stage I is generally limited disease; stages II and III include deeper invasion and/or regional nodes. In gastric cancer, stage IV means distant spread. Esophageal/GEJ staging has different groupings, including some nonmetastatic stage IVA disease, so the staging system must be stated. Clinical stage is estimated before treatment; pathological stage uses surgical tissue, and “yp” indicates assessment after preoperative therapy.

The main imaging tests

Contrast CT of the chest, abdomen and pelvis is commonly used to assess the tumour, nodes and distant organs. EUS can refine local depth and nodal assessment when useful. PET-CT is selective, especially in appropriate esophageal/GEJ pathways or uncertain distant findings; it is not mandatory for every gastric cancer. Some diffuse, mucinous and signet-ring tumours are less conspicuous on PET. MRI or biopsy may clarify an indeterminate lesion.

Why laparoscopy can change the plan

A staging laparoscopy uses small incisions to inspect abdominal surfaces and collect washings for cytology. It is particularly useful when a potentially resectable gastric cancer has a meaningful risk of occult peritoneal spread. Tiny deposits may be invisible on CT or PET. Cancer cells in peritoneal washings are treated as metastatic disease in gastric staging, even without visible deposits. A negative scan therefore cannot guarantee that surgery will be curative.

Resectable is not the same as operable

Resectable means the team believes complete removal is technically possible. Operable also considers whether the person can safely tolerate the operation. Distant metastases, extensive involvement of critical structures, severe frailty or other illnesses can change the plan. Regional nodes do not automatically rule out curative treatment. The team considers nutrition and organ function alongside the scans.

Turning results into a plan

Ask for the exact site, histology, staging system, TNM and evidence for any suspected metastasis. If one uncertain lesion would change treatment from curative to palliative, further clarification may be valuable when feasible. The multidisciplinary team should explain whether the next step is endoscopic treatment, perioperative treatment and surgery, or disease-control therapy.

Key takeaways

Accurate staging includes the possibility of microscopic disease that imaging cannot see.

Frequently asked questions

Does a negative PET exclude spread?

No. Small deposits and less FDG-avid tumours can be missed.

Does a large tumour always mean stage IV?

No. Distant spread, rather than size alone, determines metastatic status.

Are positive washings important without visible deposits?

Yes. In gastric cancer, malignant peritoneal cytology is classified as metastatic disease.

Can staging change after surgery?

Yes. Surgical and pathological findings can refine the clinical estimate.

Must everyone have laparoscopy?

No. It is selected according to the risk of occult spread and whether findings would change treatment.

Does stage IV always mean no treatment?

No. Systemic and supportive treatments can offer meaningful benefit.

References and further reading